Wordt geladen...
VIP and endothelin receptor antagonist: An effective combination against experimental pulmonary arterial hypertension
BACKGROUND: Pulmonary Arterial Hypertension (PAH) remains a therapeutic challenge, and the search continues for more effective drugs and drug combinations. We recently reported that deletion of the vasoactive intestinal peptide (VIP) gene caused the spontaneous expression of a PH phenotype that was...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3210095/ https://ncbi.nlm.nih.gov/pubmed/22029879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-12-141 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|